Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer…
Despite the fact of availability of several treatments for breast cancer, most of them fail to attain the desired therapeutic response due to their poor bioavailability, high doses, non-selectivity and as a result systemic toxicity. Here in…